Petra E. Szili
Szeged, CS, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Addendum: ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro.
Journal: Nature microbiology
Published: February 06, 2026
Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance.
Journal: Science translational medicine
Published: January 08, 2025
Exploring the principles behind antibiotics with limited resistance.
Journal: Nature communications
Published: September 30, 2024
New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity.
Journal: RSC advances
Published: July 02, 2024
Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria.
Journal: European journal of medicinal chemistry
Published: April 26, 2024
Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.
Journal: European journal of medicinal chemistry
Published: April 11, 2024
ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro.
Journal: Nature microbiology
Published: July 23, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus.
Journal: Journal of medicinal chemistry
Published: March 06, 2023
Characterization of antibiotic resistomes by reprogrammed bacteriophage-enabled functional metagenomics in clinical strains.
Journal: Nature microbiology
Published: November 26, 2021
Rationally designed foldameric adjuvants enhance antibiotic efficacy via promoting membrane hyperpolarization.
Journal: Molecular systems design & engineering
Published: August 17, 2021
Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation.
Journal: Pharmaceutics
Published: November 30, 2020
Last Updated: 09/26/2026